Local 12: COVID-19 antiviral pill in the works
UC infectious disease expert explains how the medication would work
The next major development in the fight against COVID-19 may not be a patch or a shot, but rather, a pill.
WKRC-TV, Local 12 reported that several pills are now in development to work against COVID-19. Pfizer has one in the works. Others being studied would work much like those that work in HIV.
Researchers at UC are studying a pill known as AT527. Like other antivirals, it would come in pill form. The hope is that it could be given to help those with COVID-19 before they develop serious symptoms.
The TV station interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine about the COVID-19 AT527 pill.
“Antiviral medications are looking to interrupt the virus from reproducing itself or either attaching to the person’s body,” Fichtenbaum said.
Ideally, the drug he’s researching, along with Pfizer’s and others from Merck & Co. and Ridgeback Biotherapeutics, would protect against intensive care unit admissions. They could also lead to faster recovery times, reducing the risk for long COVID symptoms.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
Early results from the COVID-19 antiviral pill trials could come as soon as late fall or winter, but they likely won’t be available to have on hand if you were exposed to the virus.
“Most of the medications are being studied to treat people early on to keep them from getting sicker and ending up in the hospital. And then some of the medications are being given to people who are in the hospital and fairly sick to see if it will make them less sick,” Fichtenbaum said.
He also points out that we do have a way to prevent the virus symptoms already: Vaccines are our best option.
Fichtenbaum was also interviewed by Local 12 for a story about experts advising against "mixing and matching" COVID-19 booster shots. See that coverage here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.